Press Room

Latest news

noviembre 17, 2017

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

AAA today announced its financial results for the third quarter ended September 30, 2017. Total sales for the third quarter of 2017 were €37.2 million (US$43.9 million), a 39% increase compared to €26.7 million (US$31.5 million) in the third quarter of 2016.

agosto 28, 2017

Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium Lu 177 Dotatate (Lutathera®)

AAA today announced that the US Food and Drug Administration (FDA) has acknowledged receipt and considered complete the resubmission of the New Drug Application (NDA) for investigational drug lutetium Lu 177 dotatate* (Lutathera®). The Agency provided a new Prescription Drug User Fee Act (PDUFA) date of January 26, 2018.

Latest Press Releases

diciembre 7, 2017

Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer

diciembre 5, 2017

Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis

Upcoming Events

AAA will be present at the following events